Cowealth Medical Holding Co., Ltd. Statistics
Cowealth Medical Holding Co., Ltd. (4745) Stock Statistics & Valuation Metrics
Total Valuation
Cowealth Medical Holding Co., Ltd. has a market cap or net worth of TWD 688.69M. The enterprise value is TWD 4.02B.
- Market Cap
- TWD 688.69M
- Enterprise Value
- TWD 4.02B
Share Statistics
Cowealth Medical Holding Co., Ltd. has 66,220,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 66,220,550
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Cowealth Medical Holding Co., Ltd.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -4.54%.
- Return on Equity (ROE)
- -0.09
- Return on Assets (ROA)
- -0.04
- Return on Invested Capital (ROIC)
- -4.54%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 3.22M
- Profits Per Employee
- -268.29K
- Employee Count
- 919
- Asset Turnover
- 0.42
- Inventory Turnover
- 3.46
Valuation Ratios
The current PE Ratio of Cowealth Medical Holding Co., Ltd. is -3.20. Cowealth Medical Holding Co., Ltd.’s PEG ratio is 0.02.
- PE Ratio
- -3.20
- PS Ratio
- 0.24
- PB Ratio
- 0.27
- Price to FCF
- -1.26
- Price to Operating Cash Flow
- -1.38
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Cowealth Medical Holding Co., Ltd. had revenue of 2.96B and earned -246.56M in profits. Earnings per share was -3.18.
- Revenue
- 2.96B
- Gross Profit
- 353.22M
- Operating Income
- -275.42M
- Pretax Income
- -285.30M
- Net Income
- -246.56M
- EBITDA
- -225.35M
- Earnings Per Share (EPS)
- -3.18
Cash Flow
In the last 12 months, operating cash flow was -532.04M and capital expenditures -11.17M, giving a free cash flow of -543.21M billion.
- Operating Cash Flow
- -532.04M
- Free Cash Flow
- -543.21M
- Free Cash Flow per Share
- -7.67
Dividends & Yields
Cowealth Medical Holding Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -80.03%
- Earnings Yield
- -40.62%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- -36.59%
- 50-Day Moving Average
- 11.79
- 200-Day Moving Average
- 15.66
- Relative Strength Index (RSI)
- 19.38
- Average Volume (3m)
- 24.16K
Important Dates
Cowealth Medical Holding Co., Ltd. upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Mar 13, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
Cowealth Medical Holding Co., Ltd. as a current ratio of 2.79, with Debt / Equity ratio of 35.13%
- Current Ratio
- 2.79
- Quick Ratio
- 2.41
- Debt to Market Cap
- 0.51
- Net Debt to EBITDA
- -0.29
- Interest Coverage Ratio
- -12.12
Taxes
In the past 12 months, Cowealth Medical Holding Co., Ltd. has paid 45.81M in taxes.
- Income Tax
- 45.81M
- Effective Tax Rate
- -0.16
Enterprise Valuation
Cowealth Medical Holding Co., Ltd. EV to EBITDA ratio is -2.69, with an EV/FCF ratio of -1.27.
- EV to Sales
- 0.24
- EV to EBITDA
- -2.69
- EV to Free Cash Flow
- -1.27
- EV to Operating Cash Flow
- -1.30
Balance Sheet
Cowealth Medical Holding Co., Ltd. has TWD 636.46M in cash and marketable securities with TWD 601.44M in debt, giving a net cash position of TWD 35.02M billion.
- Cash & Marketable Securities
- TWD 636.46M
- Total Debt
- TWD 601.44M
- Net Cash
- TWD 35.02M
- Net Cash Per Share
- TWD 0.53
- Tangible Book Value Per Share
- TWD 69.06
Margins
Gross margin is 13.32%, with operating margin of -10.20%, and net profit margin of -10.17%.
- Gross Margin
- 13.32%
- Operating Margin
- -10.20%
- Pretax Margin
- -10.27%
- Net Profit Margin
- -10.17%
- EBITDA Margin
- -8.85%
- EBIT Margin
- -10.00%
Analyst Forecast
The average price target for Cowealth Medical Holding Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -21.10%
- EPS Growth Forecast
- -366.73%
